Dolby Laboratories Inc. (DLB)
Dolby Laboratories Statistics
Share Statistics
Dolby Laboratories has 96.38M shares outstanding. The number of shares has increased by 0.57% in one year.
| Shares Outstanding | 96.38M |
| Shares Change (YoY) | 0.57% |
| Shares Change (QoQ) | 0.8% |
| Owned by Institutions (%) | 57.89% |
| Shares Floating | 95.15M |
| Failed to Deliver (FTD) Shares | 120 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 887.73K, so 0.93% of the outstanding shares have been sold short.
| Short Interest | 887.73K |
| Short % of Shares Out | 0.93% |
| Short % of Float | 0.94% |
| Short Ratio (days to cover) | 3.21 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 18.56. Dolby Laboratories's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | 18.56 |
| PS Ratio | 5.67 |
| Forward PS | 5.1 |
| PB Ratio | 2.92 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Dolby Laboratories Inc. has an Enterprise Value (EV) of 6.9B.
| EV / Earnings | 19.13 |
| EV / Sales | 5.42 |
| EV / EBITDA | 26.7 |
| EV / EBIT | 26.7 |
| EV / FCF | 23.21 |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of undefined.
| Current Ratio | 2.86 |
| Quick Ratio | 2.78 |
| Debt / Equity | undefined |
| Total Debt / Capitalization | 1.86 |
| Cash Flow / Debt | 6.96 |
| Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is 0.15% and return on capital (ROIC) is 11.77%.
| Return on Equity (ROE) | 0.15% |
| Return on Assets (ROA) | 0.12% |
| Return on Capital (ROIC) | 11.77% |
| Revenue Per Employee | $612,365.87 |
| Profits Per Employee | $173,385.58 |
| Employee Count | 2,080 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 4.17 |
Taxes
| Income Tax | -48.16M |
| Effective Tax Rate | -0.15 |
Stock Price Statistics
The stock price has increased by -3.84% in the last 52 weeks. The beta is 1, so Dolby Laboratories's price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -3.84% |
| 50-Day Moving Average | 82.19 |
| 200-Day Moving Average | 77.41 |
| Relative Strength Index (RSI) | 42.94 |
| Average Volume (20 Days) | 501.07K |
Income Statement
In the last 12 months, Dolby Laboratories had revenue of 1.27B and earned 360.64M in profits. Earnings per share was 3.77.
| Revenue | 1.27B |
| Gross Profit | 1.13B |
| Operating Income | 258.33M |
| Net Income | 360.64M |
| EBITDA | 258.33M |
| EBIT | 258.33M |
| Earnings Per Share (EPS) | 3.77 |
Balance Sheet
The company has 482.05M in cash and 46.99M in debt, giving a net cash position of 435.06M.
| Cash & Cash Equivalents | 482.05M |
| Total Debt | 46.99M |
| Net Cash | 435.06M |
| Retained Earnings | 2.5B |
| Total Assets | 3.11B |
| Working Capital | 776.58M |
Cash Flow
In the last 12 months, operating cash flow was 327.25M and capital expenditures -30.01M, giving a free cash flow of 297.25M.
| Operating Cash Flow | 327.25M |
| Capital Expenditures | -30.01M |
| Free Cash Flow | 297.25M |
| FCF Per Share | 3.11 |
Margins
Gross margin is 88.97%, with operating and profit margins of 20.28% and 28.31%.
| Gross Margin | 88.97% |
| Operating Margin | 20.28% |
| Pretax Margin | 24.53% |
| Profit Margin | 28.31% |
| EBITDA Margin | 20.28% |
| EBIT Margin | 20.28% |
| FCF Margin | 23.34% |
Dividends & Yields
DLB pays an annual dividend of $1.56, which amounts to a dividend yield of 1.51%.
| Dividend Per Share | $1.56 |
| Dividend Yield | 1.51% |
| Dividend Growth (YoY) | 10% |
| Payout Ratio | 57.78% |
| Earnings Yield | 4.69% |
| FCF Yield | 3.84% |
Analyst Forecast
The average price target for DLB is $100, which is 24.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $100 |
| Price Target Difference | 24.5% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | 9.45 |
| Piotroski F-Score | 7 |